Author Instructions for Japanese Journal of PharmaceuticalEducation (JJPhE)
Journal Name (Eng):Japanese Journal of Pharmaceutical Education (JJPhE)

Journal Name (Jps):

Yakugaku Kyoiku

Issuing Authority:

Japan Society for Pharmaceutical Education

Location:

Bunkyo-ku, Tokyo

Year Established:

2017

ISSN:

ONLINE ISSN (ISSN-L)

2433-4774

PRINT ISSN 2432-4124
Mission:Publication of articles on pharmacy education and its related fields

Platform:

J-STAGE electronic journal articles are published online in PDF form.
The published articles are compiled and released once a year in printform.

Website:http://www.jsphe.jp/
Author instructions, guidelines, submission template and a manuscript
check sheet are on the website.

J-STAGE:https://www.jstage.jst.go.jp/browse/jjphe/-char/en

Editorial Board:

Chair - Tetsumi Irie
Members - Etsuko Arita, Satoko Ishikawa, Takeshi Ito
Denise Epp, Koichiro Ozawa, Miwako Kamei, Hiroshi Kosano,
Kayoko Takeda Mamiya, Sumio Matsuno, Junichi Yamada

Editorial Office:

JJPhE Editorial OfficeNakanishi Printing Co., Ltd.
Shimodachiuri Ogawa, Kamigyo-ku, Kyoto 602-8048, Japan
E-mail: jjphe-ed@nacos.com
TEL:+81-75-441-3155

FAX:+81-75-417-2050

Author Instructions for Japanese Journal of Pharmaceutical
Education (JJPhE)(Referred to herein as The Journal)

Introduction
1. Objectives of The Journal
The Journal is the academic journal of the Japan Society for Pharmaceutical Education (herein The Society),and publishes articles on pharmacy education and its related research fields.
2. Publication schedule
The Journal is published periodically online in “J-STAGE”, an electronic journal platform for science andtechnology information in Japan, managed by the Japan Science and Technology Agency (JST). All papers
from the calendar year are published in one volume annually in January. The booklet is printed inmonochrome.
3. Submission qualification
The first author in manuscripts must be a member of The Society. However, this does not apply tomanuscripts invited by the editorial board.
4. Publication categories
1) The submitted manuscript shall be one of the following categories.
[Original Article]
A paper on pharmacy education and its related research fields, which isoriginal and novel, based on a well-defined research question with suitable
research methods, clear results, and scientifically based facts and conclusions.
[Short Communication] A paper that announces timely and significant findings in pharmacy educationand its related research fields, based on limited evidence and experience.
[Review Article]
A paper that examines and provides a critical analysis of specific topics inpharmacy education and its related research fields, based on evidence obtainedby authors and others. The paper is invited by the editorial board in principle.
[Practical Article]
A paper that focuses on creative or novel approaches to teaching and learning
activities in pharmacy education and its related research fields.
2) Submitted manuscripts should be unpublished and not under consideration elsewhere. Duplicate
submissions are prohibited.
5. Language
The language of publication for The Journal is Japanese or English. Non-native English speakers shouldhave the manuscript edited by a native English speaker before submission.
6. Ethical considerations
・The research for submitted manuscripts should comply with related laws, regulations, guidelines, andpolicies.
・Research on human subjects should be conducted with ethical considerations for the research subjects.
・Research that requires an ethical review because it falls under the ethical guidelines or a clinical researchact (for example, it involves human subjects and the handling of personal information) must be approved

by the ethics review committee of the institution to which the contributor belongs, prior to the start of
the research. An explanation detailing the ethical considerations and the approval number of the ethics
review committee should be included in the “Method” section of the manuscript.
7. Manuscript review
1) Submitted manuscripts are peer-reviewed for consideration for publication. Acceptance of themanuscript is determined by the editorial board, based on opinions of peer-reviewers.
2) According to the judgment of the editorial board, there are cases where the author may be requested tochange the category of manuscript publication.
3) Position of posting in The Journal is decided by the editorial board. In principle, posting will be in orderof acceptance.
8. Conflict of interest
All authors are required to declare conflict of interest in their research when submitting a manuscript toThe Journal.
9. CopyrightThe copyright of published manuscripts in The Journal belongs to The Society.
10. Publication costs
1) Costs are set at 3,000 yen per page for publishing.
2) When publishing at J-STAGE, even if the figures or pictures are in color, there is no cost burden to theauthor. However, the booklet is printed in monochrome.
3) Reprints can be ordered at the time of author proofreading and expenses for reprints shall be paid byauthors, including the printing and shipping fees.
11. Author proofreading
The corresponding author is responsible for proofreading the typeset article that may include revisions
made by the editorial office. The proofreading is limited to errors that may derive from typesetting andeditorial revision.
12. Inquiries about submitted manuscripts
Manuscripts must be submitted with the WEB submission form for The Journal (URL below). The numberof electronic files of submitted manuscripts is limited to 4 or less (within 5 files, including the manuscript
check sheet) with a total file size of 5 MB or less. If it is difficult to access the WEB submission form, mailone printed copy of the manuscript along with a copy of the data saved on an electronic medium (i.e. CD-R)
to the editorial office. Please note that electronic media such as CD-Rs sent will not be returned.
<WEB submission form>
http://www.jsphe.jp/journal<Manuscript delivery address / Inquiries destination>
JJPhE Editorial OfficeNakanishi Printing Co., Ltd.
Shimodachiuri Ogawa, Kamigyo-ku, Kyoto 602-8048, Japan
E-mail: jjphe-ed@nacos.com TEL: +81-75-441-3155

FAX: +81-75-417-2050

Essentials for Writing
1. Manuscript submission form and checklist
When submitting the manuscript, use the manuscript submission form on The Journal website(http://www.jsphe.jp/journal). All manuscripts must be submitted via this form. The author must attach thefilled-out manuscript submission checklist, which can be downloaded from The Journal website.
2. Manuscript style1) The manuscript should be created using the submission template, with numbers and symbols in halfwidth characters. English manuscripts should be double spaced, Times New Roman, 11 font, with noncontinuous line numbering and no page breaks.
2) Manuscripts should be organized in the following order: title page, abstract, text (with “Purpose”,“Method”, “Results”, “Conclusion”), references, tables, figures, and appendices. The format may differ
for “Review Articles” and “Practical Articles”.
3) The Title Page should include the title, authors’ names, and affiliations in both Japanese and English,
followed by the corresponding author’s name, address, telephone number and e-mail address at thebottom. If there is more than one author, a superscripted number should be appended to the author’sname. The corresponding author should add a superscript asterisk (*) after the affiliation number. On
the right upper side of the title page, clearly state the publication category of the paper “Original Article”,“Short Communication”, “Review Article”, or “Practical Article”.
4) A Japanese abstract (within 400 characters) or an English abstract (within 250 words) must be included
with the manuscript. There should also be up to 5 keywords (in Japanese and English respectively).
These keywords should be words, not sentences. English abstracts should be reviewed before
submission by a native English speaker.
5) All attached figures (including graphs and photographs) and tables should be on separate pages at theend of the text. The image and writing must be clear.
6) Supplementary materials may be published in J-STAGE upon request of the author(s) and when deemed
appropriate by the Editorial Board. If an electronic supplement is included, the statement "The J-STAGE
online journal version of this article includes an electronic supplement (supplementary materials)"should be included at the end of the manuscript (after the conflict of interest statement).
3. Document length
1) “Original Articles” and “Review Articles” should not exceed 16 pages of A4 size paper (about 12,800
characters in Japanese and 250 words per page in English; corresponding to 8 printed pages of TheJournal) including attached figures and tables. “Short Communication” and “Practical Articles” should
not exceed 12 pages (equivalent to 6 pages of The Journal).
2) As a general rule, figures or tables should not be larger than half an A4 page.
4. Word style1) Uncommon foreign words or names for people and places should be written using the Roman alphabet
or in English. Generic drug names are used with the brand name written in parentheses. When describing
specific chemicals, equipment and materials, include the product name, trademark or registeredtrademark.
2) Abbreviations for words that are repeated in the paper may be used, but the abbreviation should beplaced in parentheses immediately following its first use in the main body of the text. The words shownin Appendix 1 can be used without spelling them out.

3) The metric (SI) system (mm, cm, mL, dL, mg, kg, etc.) should be used for measurements.
5. Conflict of interest
State any “conflict of interest” at the end of the text (before the references) as follows:
1) If there is no conflict of interest to be disclosed, write:“There is no conflict of interest to be disclosed in relation to the contents of this paper.”2) If there is a conflict to be disclosed: Describe the name of the author and the contents to be disclosed.
[For example] Conflicts of interest to be disclosed in relation to the contents of this paper are shown
below.
1. Officer / advisor: Yes (author name, XX Pharmaceutical)
2. Shareholding status: Yes (author name, XX Pharmaceutical)
3. Patent royalty: Yes (author name, XX Pharmaceutical)
4. Presentation fee, manuscript fee: Yes (author name, XX Pharmaceutical)
5. Commissioned research fund, Collaborative research, Gift/donation: Yes (author name, XXPharmaceutical)
6. Position maintained by gift/donation: (author name, XX Pharmaceutical)
6. References
References should be limited to those directly related to the text, numbered sequentially with superscripted
numbers, and enumerated in numerical order in the reference list every time they are cited in the text
(according to the Vancouver style of referencing). Descriptions of bibliographic information in the literatureand citing are in accordance with the “Unified Regulations for Submitting Manuscripts to Biomedical
Journals” with authors and co-authors written up to three people, and from the fourth person onwards
abbreviated using “et al.” Japanese journals are written with the complete name. For English journals, use
the abbreviated journal name as adopted in Index Medicus. Refer to the reference examples in Appendix 2.
7. Manuscript format
We recommend the following format for manuscript data. File names should use half-width alphanumericcharacters only. Do not use spaces, periods, circled numerals such as ①②, or Roman numerals such as Ⅰ
and Ⅱ in file names. Since there is a limit of 4 files per submission (up to 4 pages excluding the submissionform), consider creating one Excel file with separate sheets for multiple tables.
Text: Microsoft Word (obtain and use template file from the website)
Tables: Microsoft Word, or Microsoft ExcelFigures (graph / photo): Microsoft PowerPoint, Microsoft Word (check the resolution when pasting intoa file), PDF, PSD (Adobe Photoshop), AI (Adobe Illustrator)* Create clear figures that are readable when printed. Consider the color scheme and contrast for display
in J-STAGE and the monochrome printing of The Journal.
* For the image resolution, the following settings are preferred:[Photos] Finished size 300 dpi[Line drawings] Finished size 1000 dpi
For inquiries, contact the editorial office.
8. Reviewer request
1) The author should specify 4 potential reviewers to review the submitted manuscript. The reviewers
should be experts in their fields who can provide fair and accurate advice and state whether they have arelationship (ongoing or past) with the author(s).
2) Attach the reason if there is a wish to avoid a specific reviewer.

3)

The editorial board is not restricted by the requests for reviewers. In addition, the information obtained
will not be open to the public.

9. Points to note when submitting revised manuscripts
1) Prepare a detailed response corresponding to each comment by the peer reviewer. Also, show the revised
text sections in red to indicate the areas that were changed.
2) Post the revised manuscript within 2 months of the reviewer’s comments. If you need more time, contact
the editorial office. If there is no contact made and the revision date has been exceeded, it will be treatedas “a withdrawal”.

Appendix 1 Abbreviations that can be used without spelling out in the text
(The latest list is on the website.)
CBTGIOOSCEOTC
QOL
SBO
SGD
WHO

Computer-Based Testing
General Instructional Objective
Objective Structured Clinical Examination
Over the Counter
Quality of Life
Specific Behavioral Objective
Small Group Discussion
World Health Organization

Appendix 2 References and Citations
Refer to the International Committee of Medical Journal Editors “Uniform Regulations for Submitting
Manuscripts
toBiomedicalJournals”
guidelinesforsubmitting
manuscripts(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142758/) and the US National Library of Medicine’s styleguideforreferencesandcitations
in“NLM
CitingMedicine,2ndedition”(https://www.ncbi.nlm.nih.gov/sites/books/NBK7256/). The accepted abbreviations adopted by Index
Medicus can be found on the following NLM website: https://www.nlm.nih.gov/bsd/num_titles.html.